TRCT
BAK icon

Tower Research Capital (TRC)’s Braskem BAK Stock Holding History

Tower Research Capital (TRC)’s Portfolio BAK Stock Details BAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$640 Sell
175
-703
-80% -$2.66K ﹤0.01% 4816
2025
Q4 		$2.59K Sell
878
-2,522
-74% -$6.91K ﹤0.01% 4497
2025
Q3 		$8.23K Buy
3,400
+2,681
+373% +$8.6K ﹤0.01% 4058
2025
Q2 		$2.36K Buy
719
+619
+619% +$2.24K ﹤0.01% 4663
2025
Q1 		$385 Sell
100
-237
-70% -$984 ﹤0.01% 4910
2024
Q4 		$1.3K Buy
337
+191
+131% +$1.05K ﹤0.01% 5051
2024
Q3 		$1.07K Sell
146
-134
-48% -$879 ﹤0.01% 5210
2024
Q2 		$1.81K Sell
280
-11,704
-98% -$93.1K ﹤0.01% 5088
2024
Q1 		$126K Buy
11,984
+10,705
+837% +$87.3K ﹤0.01% 1708
2023
Q4 		$11.3K Sell
1,279
-753
-37% -$5.75K ﹤0.01% 4143
2023
Q3 		$16.7K Buy
2,032
+1,110
+120% +$10.7K ﹤0.01% 3536
2023
Q2 		$10.7K Buy
922
+869
+1,640% +$8.23K ﹤0.01% 4071
2023
Q1 		$0 Buy
+53
New +$430 ﹤0.01% 5802
2022
Q4 		– Sell
-243
Closed -$2K – 5880
2022
Q3 		$2K Buy
243
+205
+539% +$2.56K ﹤0.01% 5529
2022
Q2 		$1K Sell
38
-532
-93% -$9.11K ﹤0.01% 5732
2022
Q1 		$11K Buy
+570
New +$10.8K ﹤0.01% 4144
2021
Q3 		– Sell
-1,287
Closed -$31K – 5757
2021
Q2 		$31K Buy
+1,287
New +$25.7K ﹤0.01% 3445
2020
Q4 		– Sell
-312
Closed -$2K – 5121
2020
Q3 		$2K Sell
312
-4,318
-93% -$37.1K ﹤0.01% 4569
2020
Q2 		$40K Buy
4,630
+1,612
+53% +$13.9K ﹤0.01% 3223
2020
Q1 		$20K Buy
3,018
+2,793
+1,241% +$35.6K ﹤0.01% 1706
2019
Q4 		$3K Buy
+225
New +$3.15K ﹤0.01% 2872
2019
Q2 		– Sell
-8,467
Closed -$218K – 3659
2019
Q1 		$218K Buy
8,467
+7,467
+747% +$207K 0.01% 1103
2018
Q4 		$24K Buy
+1,000
New +$27.1K ﹤0.01% 1782
2018
Q2 		– Sell
-1,296
Closed -$38K – 3634
2018
Q1 		$38K Sell
1,296
-1,085
-46% -$31.6K ﹤0.01% 1819
2017
Q4 		$63K Buy
+2,381
New +$68K 0.01% 1158
2017
Q3 		– Sell
-10,574
Closed -$219K – 3769
2017
Q2 		$219K Buy
10,574
+10,474
+10,474% +$216K 0.02% 322
2017
Q1 		$2K Sell
100
-1,171
-92% -$24.6K ﹤0.01% 2591
2016
Q4 		$27K Buy
1,271
+636
+100% +$11.2K ﹤0.01% 1871
2016
Q3 		$10K Sell
635
-1,061
-63% -$13.9K ﹤0.01% 2044
2016
Q2 		$20K Sell
1,696
-3,937
-70% -$49K ﹤0.01% 2223
2016
Q1 		$73K Sell
5,633
-4,327
-43% -$55.3K 0.01% 595
2015
Q4 		$135K Buy
9,960
+4,181
+72% +$51K 0.02% 249
2015
Q3 		$49K Buy
+5,779
New +$44.6K ﹤0.01% 1030
2015
Q2 		– Sell
-178
Closed -$1K – 4373
2015
Q1 		$1K Sell
178
-3,432
-95% -$31.4K ﹤0.01% 4015
2014
Q4 		$46K Buy
+3,610
New +$50.5K ﹤0.01% 1065
2014
Q3 		– Sell
-1,184
Closed -$15K – 4410
2014
Q2 		$15K Sell
1,184
-5,962
-83% -$82.6K ﹤0.01% 2029
2014
Q1 		$112K Buy
+7,146
New +$108K 0.01% 645
2013
Q3 		– Sell
-1,823
Closed -$27K – 4544
2013
Q2 		$27K Buy
+1,823
New +$28.5K ﹤0.01% 1430

Other funds holding BAK

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return
LCM
Lonestar Capital Management San Francisco, California $671M AUM 72.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tower Research Capital (TRC)'s BAK Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Braskem (BAK) stake by 80% in Q1 2026, selling an estimated $2.66K and leaving 175 shares worth $640. The position accounts for ﹤0.01% of the portfolio, ranked #4816.

Tower Research Capital (TRC) first reported a position in BAK in Q2 2013 and has held it in 38 quarters since. The position peaked at $219K in Q2 2017. 64 funds tracked by Wall St. Rank hold BAK as of Q1 2026.

  • Tower Research Capital (TRC) held 175 shares of Braskem worth $640 as of Q1 2026.
  • Tower Research Capital (TRC) sold 703 Braskem shares in Q1 2026, an estimated $2.66K.
  • Braskem made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4816 holding.
  • Tower Research Capital (TRC) first reported a position in Braskem in Q2 2013 and has held it in 38 quarters since.
  • Tower Research Capital (TRC)'s Braskem position peaked at $219K in Q2 2017.
  • 64 funds tracked by Wall St. Rank held Braskem as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.